Richard Rowland
Family Medicine · Hondo, TXNPI 1750300208
Payments from drug & device makers
Across 142 payments — averaging $14.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$848
- Novo Nordisk$293
- Astellas Pharma US Inc$156
- Merck$122
- GSK$113
- AstraZeneca$103
- plus $462 from 14 others
What the payments were for
- Food & beverage$2,01796%
- Education$804%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $848 |
| Novo Nordisk | 18 | $293 |
| Astellas Pharma US Inc | 6 | $156 |
| Merck | 8 | $122 |
| GSK | 4 | $113 |
| AstraZeneca | 5 | $103 |
| Supernus Pharmaceuticals, Inc. | 6 | $94 |
| Amgen | 4 | $67 |
| Johnson & Johnson | 4 | $49 |
| Novartis | 3 | $46 |
| Bayer | 2 | $35 |
| Pfizer | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| SK Life Science, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Corium, LLC | 1 | $18 |
| Averitas Pharma Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $12 |
How this compares
$2,097 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 392 | $380,130 |
| MounjaroTirzepatide | 173 | $196,850 |
| FarxigaDapagliflozin Propanediol | 168 | $143,958 |
| EliquisApixaban | 147 | $110,313 |
| JanuviaSitagliptin Phosphate | 48 | $54,676 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 61 | $41,236 |
| RybelsusSemaglutide | 25 | $38,590 |
| JardianceEmpagliflozin | 25 | $38,582 |
| Trokendi XrTopiramate | 13 | $34,535 |
| TrulicityDulaglutide | 27 | $28,610 |
| Tresiba Flextouch U-200Insulin Degludec | 24 | $22,508 |
| Tresiba Flextouch U-100Insulin Degludec | 43 | $21,422 |
| XareltoRivaroxaban | 14 | $15,918 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 15 | $14,273 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $13,634 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $293 | $418,720417 claims |
| Lilly USA, LLCMounjaro, Trulicity | $15 | $225,460200 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $103 | $163,254214 claims |
| PfizerEliquis, Premarin | $30 | $115,347159 claims |
| MerckJanuvia, Janumet Xr | $122 | $68,94963 claims |
| GSKTrelegy Ellipta | $113 | $41,23661 claims |
| Supernus Pharmaceuticals, Inc.Trokendi Xr | $94 | $34,53513 claims |
| AbbVieLinzess, Restasis, Synthroid | $848 | $22,68661 claims |
| Johnson & JohnsonXarelto | $49 | $15,91814 claims |
| Astellas Pharma US IncMyrbetriq | $156 | $11,42014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Hondo
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.